Balchem

Balchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, Specialty Products and Industrial Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment comprises nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The Industrial Products segment refers to certain derivatives of choline chloride which manufactured and sold into industrial applications as a component for hydraulic fracturing of shale natural gas wells. The company was founded in January 1967 and is headquartered in Montvale, NJ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Balchem reports record 2022 earnings, eyes growth amid challenges

Balchem's strong performance in 2022, driven by record sales and earnings, positions them well for future growth. Strategic acquisitions and market studies provide opportunities for expansion despite temporary challenges.

Balchem reports record Q1 revenues, navigates market challenges strategically

Balchem's Q1 2023 performance reflects solid financial results, operational efficiency, and progress in sustainability initiatives.
Despite market challenges, the company showcased resilience, innovation, and a strategic focus on long-term growth.
Opportunities for growth and differentiation exist through market expansion, product innovation, and continued sustainability efforts.
Balchem's strong financial foundation, coupled with a commitment to sustainability, underpins its strategic positioning for future success.

Balchem reports stable Q2 earnings, eyes growth in nutrition sector

Balchem delivered a mixed performance in Q2 2023 with revenue decline but improved profitability metrics.
The company faces challenges in revenue growth and leadership transition but maintains financial stability.
Opportunities lie in exploring new markets, leveraging cash reserves, and capitalizing on manufacturing investments.

Balchem (BCPC) reports solid Q3 results amid market challenges

Balchem's Q3 performance reflects resilience amidst challenges, with a focus on innovation, quality, and operational efficiency.
While facing market uncertainties and higher interest expenses, the company's strategic strengths in key segments position it for growth.
Opportunities lie in leveraging partnerships, consumer awareness efforts, and strategic initiatives to drive future sales and profitability.

Balchem reports record earnings in Q4 2023, eyes growth opportunities

Balchem's Q4 2023 performance showcased resilience with record earnings and strong profitability despite challenges in certain segments. Strategic initiatives and focus on sustainability and growth areas like Human Nutrition & Health position the company well for future success. Optimism for 2024 and potential partnerships signal a promising outlook for Balchem.

Balchem reports robust Q1 earnings, focuses on growth strategies

Balchem's Q1 2024 performance reflects strong financial results, driven by record sales and adjusted EBITDA, despite challenges in specific segments.
The company's focus on sustainability, marketing initiatives, and margin improvement positions it well for future growth and market expansion.
Addressing challenges in the Animal Nutrition & Health segment while leveraging opportunities in key segments like Human Nutrition & Health is crucial for sustained success.
Balchem's strategic partnerships, marketing efforts, and participation in investor conferences signal a proactive approach to driving growth and enhancing shareholder value.

Balchem reports solid Q2 earnings, eyes growth amid segment challenges

Balchem's Q2 2024 performance reflects resilience and growth, particularly in the Human Nutrition & Health and Specialty Products segments, despite challenges in the Animal Nutrition & Health segment.
The company's focus on innovation, debt reduction, and operational efficiency positions it well for future opportunities and sustained financial strength.
With a solid financial foundation, Balchem is poised to navigate challenges, capitalize on growth opportunities, and drive value for shareholders in the coming quarters.

Balchem (BCPC) reports record earnings, eyes growth amid margin challenges

Balchem (BCPC) delivered strong financial results in Q3 2024, driven by solid performance across its segments and successful new product launches. While anticipating margin moderation, the company remains optimistic about continued growth opportunities, especially in key segments. Balchem's focus on strategic investments and market stability positions it well for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Balchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health and Specialty Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment consists of nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The company was founded in January 1967 and is headquartered in Montvale, NJ.

Local Bounti Corp

Steakholder Foods Ltd

If you're wondering if there are any worthwhile food stocks to own currently, look no further. Food stocks saw collective investor enthusiasm fall off a cliff in recent years.

3 Tantalizing Stocks to Invest in the Future of Food

MONTVALE, N.J., Dec. 15, 2023 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) announced that the Company has been named one of America's Most Responsible Companies by Newsweek and Statista Inc., the world-leading statistics portal and industry ranking provider. Balchem has earned a ranking amongst this prestigious list of companies for the fourth consecutive year.

Balchem Corporation Named on Newsweek's 2024 List of America's Most Responsible Companies

MONTVALE, N.J., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that on December 4, 2023, its Board of Directors declared a dividend on its shares of common stock equal to $0.79 per share on the Company's issued and outstanding Common Stock, to be payable on January 19, 2024 to stockholders of record at the close of business on December 27, 2023. This dividend represents an 11.3% increase over last year's annual dividend.

Balchem Corporation Announces Dividend

Balchem Corporation shares have come under pressure after a tough 2023 so far. The company has a strong track record and has grown its sales to nearly a billion dollars. Recent Balchem Corporation Q3 financial results show a decline in growth and weakness in the animal nutrition & health business, but I still have high regards for the business (over the long haul).

Balchem Q3: A Solid Performer Is Seeing A Soft 2023

Balchem Corporation (NASDAQ:BCPC ) Q3 2023 Earnings Conference Call October 27, 2023 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President and CEO Conference Call Participants Bob Labick - CJS Securities Anthony Polak - Aegis Capital Kyle May - Sidoti Operator Greetings, and welcome to the Balchem Third Quarter Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.

Balchem Corporation (BCPC) Q3 2023 Earnings Call Transcript

Blachem (BCPC) came out with quarterly earnings of $0.90 per share, missing the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.78 per share a year ago.

Blachem (BCPC) Q3 Earnings and Revenues Lag Estimates

MONTVALE, N.J., Oct. 27, 2023 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today third quarter net sales of $229.9 million for 2023, compared to net sales of $244.3 million in the prior year quarter.

Balchem Corporation Reports Third Quarter Sales of $229.9 Million, with Net Earnings of $29.1 Million, GAAP EPS of $0.90, and Adjusted EPS of $1.04

MONTVALE, N.J., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, October 27th at 11:00 AM Eastern Time (ET) to review third quarter results.

Balchem Corporation Announces Quarterly Conference Call for Third Quarter Financial Results on October 27, 2023

Mativ Inc

Investors interested in stocks from the Chemical - Specialty sector have probably already heard of Mativ Holdings (MATV) and Blachem (BCPC). But which of these two stocks offers value investors a better bang for their buck right now?

MATV or BCPC: Which Is the Better Value Stock Right Now?

Balchem Corporation (NASDAQ:BCPC ) Q2 2023 Earnings Conference Call July 28, 2023 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President and CEO Conference Call Participants Bob Labick - CJS Securities Ram Selvaraju - H.C. Wainwright Operator Greetings and welcome to Balchem's Second Quarter 2023 Earnings Call.

Balchem Corporation (BCPC) Q2 2023 Earnings Call Transcript

Blachem (BCPC) came out with quarterly earnings of $0.93 per share, beating the Zacks Consensus Estimate of $0.80 per share. This compares to earnings of $0.92 per share a year ago.

Blachem (BCPC) Surpasses Q2 Earnings Estimates

MONTVALE, N.J., July 28, 2023 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today second quarter net sales of $231.3 million for 2023, compared to net sales of $236.7 million in the prior year quarter. Second quarter net earnings were $30.1 million for 2023, compared to net earnings of $29.8 million for the second quarter 2022. Adjusted net earnings(a) were $34.4 million for both the second quarter of 2023 and 2022. Quarterly adjusted EBITDA(a) was $59.1 million, compared to $56.5 million in the prior year quarter.

Balchem Corporation Reports Second Quarter Sales of $231.3 Million, with Net Earnings of $30.1 Million, GAAP EPS of $0.93, and Adjusted EPS of $1.06

MONTVALE, N.J., July 14, 2023 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, July 28th at 11:00 AM Eastern Time (ET) to review second quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call.

Balchem Corporation Announces Quarterly Conference Call for Second Quarter Financial Results on July 28, 2023

MONTVALE, N.J., June 06, 2023 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) Chairman, President and Chief Executive Officer Ted Harris and Chief Financial Officer Martin Bengtsson will present at the Sidoti June 2023 Virtual Small-Cap Conference on June 15, 2023. The presentation will begin at 11:30 AM EST. The link for the live webinar is listed below. The presentation will be available after the conference on Balchem's website (www.balchem.com/investor-relations)

Balchem Corporation to Present at the Sidoti June 2023 Virtual Small-Cap Conference June 15, 2023

Balchem Corporation (NASDAQ:BCPC ) Q1 2023 Earnings Conference Call April 28, 2023 11:00 AM ET Company Participants Martin Bengtsson - Chief Financial Officer Ted Harris - Chairman, Chief Executive Officer & President Conference Call Participants Mitra Ramgopal - Sidoti Bob Labick - CJS Securities Operator Greetings and welcome to Balchem's First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Balchem Corporation (BCPC) Q1 2023 Earnings Call Transcript

Blachem (BCPC) came out with quarterly earnings of $0.70 per share, missing the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.89 per share a year ago.

Blachem (BCPC) Lags Q1 Earnings Estimates

MONTVALE, N.J., April 28, 2023 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today first quarter net sales of $232.5 million for 2023, compared to net sales of $228.9 million in the prior year quarter. First quarter net earnings were $22.7 million for 2023, compared to net earnings of $28.9 million for the first quarter 2022, with adjusted net earnings(a) of $30.6 million, compared to $33.4 million in the prior year quarter. First quarter adjusted EBITDA(a) was $56.1 million, compared to $53.6 million in the prior year quarter.

Balchem Corporation Reports Record First Quarter Sales of $232.5 Million, with Net Earnings of $22.7 Million, GAAP EPS of $0.70, and Adjusted EPS of $0.94

MONTVALE, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today released its 2022 Sustainability Report, which captures the Company's commitment to integrate Environment, Social and Governance (ESG) performance into our business strategy.

Balchem Corporation Releases 2022 Sustainability Report

MONTVALE, N.J., April 14, 2023 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, April 28th at 11:00 AM Eastern Time (ET) to review first quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call.

Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on April 28, 2023

Balchem Corporation (NASDAQ:BCPC ) Q4 2022 Results Conference Call February 24, 2023 11:00 AM ET Company Participants Martin Bengtsson - Chief Financial Officer Ted Harris - Chairman, Chief Executive Officer and President Conference Call Participants Lee Jagoda - CJS Securities Ram Selvaraju - H.C. Wainwright Mitra Ramgopal - Sidoti Operator Greetings and welcome to Balchem's Fourth Quarter Year-End 2022 Earnings Conference Call.

Balchem Corporation (BCPC) Q4 2022 Earnings Call Transcript

MONTVALE, N.J., Feb. 24, 2023 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today fourth quarter net sales of $232.5 million for 2022, compared to net sales of $213.1 million for the fourth quarter 2021. Fourth quarter net earnings were $21.4 million for 2022, compared to net earnings of $24.9 million for the fourth quarter 2021, with adjusted net earnings(a) of $30.3 million, compared to $27.8 million in the prior year quarter. Fourth quarter adjusted EBITDA(a) was $52.3 million, compared to $45.6 million in the prior year quarter. Balchem Corporation also reported for the full year 2022 net sales of $942.4 million, compared to $799.0 million for 2021. Full year 2022 net earnings were $105.4 million, compared to net earnings of $96.1 million for 2021, with adjusted net earnings of $130.5 million, compared to $116.6 million in the prior year. Full year adjusted EBITDA was $216.1 million, compared to $189.8 million in the prior year.

Balchem Corporation Reports Fourth Quarter Net Sales Growth of 9.1% and Strong Full Year 2022 Results

CNH Industrial NV

Yara International ASA

Sustainable agriculture stocks are poised for strong growth in 2023. All as more people become aware of the importance of preserving agricultural resources.

3 Stocks to Buy for the Future of Sustainable Agriculture

MONTVALE, N.J., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, February 24th at 11:00 AM Eastern Time (ET) to review fourth quarter results. Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO will host the call.

Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter Financial Results on February 24, 2023

Apogee Enterprises

Algonquin Power & Utilities

Axis Capital

Bank of New York Mellon

Caterpillar

Colgate-Palmolive

Erie Indemnity

Farmers & Merchants Bancorp

First Bancorp

Gladstone Investment

General Dynamics

Great Southern Bancorp

Horizon

HEICO

Intuit

Gladstone Land

Lakeland Financial

Owens Corning

Procter & Gamble

Pentair

Republic Bancorp

Royal Gold

Roper Technologies

RPM International

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.

Dividend Champion, Contender, And Challenger Highlights: Week Of January 15

MONTVALE, N.J., Jan. 06, 2023 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) announced that the Company has been named one of America's Most Responsible Companies by Newsweek and Statista Inc., the world-leading statistics portal and industry ranking provider. Balchem has earned a ranking amongst this prestigious list of companies for the third consecutive year.

News for Balchem Stock (BCPC)